Interestingly, MH’s results are in line with the literature showing that minocycline acts as an inhibitor of an upstream suppressor of Wnt/β-catenin signalling—Dickkopf-1 (DKK1)—promoting Wnt/β-catenin pathway activation, improving β-catenin levels in perihematomal tissues in an in vivo model of intracerebral haemorrhage [30]. The gene discussed is DKK1; the disease is intracerebral hemorrhage.